This is one of the studies which were stopped due to low enrollment, so the statistical power is just not there.
The NIAID study's preliminary results (shared a couple of weeks ago) showed a 30% reduction in recovery time in people treated with remedisivir. That one had 800+ people enrolled.
The NIAID study's preliminary results (shared a couple of weeks ago) showed a 30% reduction in recovery time in people treated with remedisivir. That one had 800+ people enrolled.